Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan.

Authors

Anna E. Coghill
Ruth M. Pfeiffer
Carla Proietti
Wan-Lun Hsu
Yin-Chu Chien
Lea Lekieffre
Lutz Krause
Andy Teng
Jocelyn Pablo
Kelly J. Yu
Pei-Jen Lou
Cheng-Ping Wang
Zhiwei Liu
Chien-Jen Chen
Jaap Middeldorp
Jason Mulvenna
Jeff Bethony, George Washington University
Allan Hildesheim
Denise L. Doolan

Document Type

Journal Article

Publication Date

3-15-2018

Journal

Clinical Cancer Research

Volume

24

Issue

6

Inclusive Pages

1305-1314

DOI

10.1158/1078-0432.CCR-17-1929

Keywords

Adult; Aged; Antibodies, Viral; Case-Control Studies; Cross-Sectional Studies; Early Detection of Cancer; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Immunoglobulin A; Immunoglobulin G; Male; Mass Screening; Middle Aged; Nasopharyngeal Carcinoma; Neoplasm Staging; ROC Curve; Risk Assessment; Taiwan; Young Adult

Comments

Epub 2018 Jan 4

APA Citation

Coghill, A. E., Pfeiffer, R. M., Proietti, C., Hsu, W., Chien, Y., Lekieffre, L., Krause, L., Teng, A., Pablo, J., Yu, K. J., Lou, P., Wang, C., Liu, Z., Chen, C., Middeldorp, J., Mulvenna, J., Bethony, J., Hildesheim, A., & Doolan, D. L. (2018). Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan.. Clinical Cancer Research, 24 (6). http://dx.doi.org/10.1158/1078-0432.CCR-17-1929

Peer Reviewed

1